No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Down -35.58% in 4 Weeks, Here's Why You Should You Buy the Dip in Zura Bio Limited (ZURA)
We Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business Growth
Zura Bio Highlights Strategic Goals and Clinical Advances
Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)
Cautious Hold Rating on Zura Bio Due to Efficacy Concerns and Competitive Risks
HC Wainwright & Co. Reiterates Neutral on Zura Bio, Maintains $5 Price Target